The Ubiquitin–Proteasome System in Asthma: Mechanisms and Therapeutic Possibilities

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Clinical reviews in allergy and immunology

• Publication date

  2025-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12016-025-09081-yPMID 40935955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Probing the Kitaev honeycomb model on a neutral-atom quantum computer

  2025cited by this paper
• STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity

  2025cited by this paper
• A scalable variational inference approach for increased mixed-model association power

  2025influential reference
• Inhibition of Cullin3 Neddylation Alleviates Diabetic Retinopathy by Activating Nrf2 Signaling to Combat ROS-Induced Oxidative Stress and Inflammation

  2025cited by this paper
• Identification and Experimental Validation of OS-Related Gene Sets Based on Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data with Machine Learning in Patients with Sepsis

  2025cited by this paper
• Innate Immunity and Asthma Exacerbations: Insights From Human Models

  2025cited by this paper
• GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region

  2024influential reference
• The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity

  2024influential reference
• Allergic diseases and T2DM: a bidirectional multivariable Mendelian randomization study and mediation analysis

  2024cited by this paper
• Novel hypoxia-induced HIF-1αactivation in asthma pathogenesis

  2024cited by this paper
• Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader.

  2024cited by this paper
• Database resources of the National Center for Biotechnology Information in 2025.

  2024cited by this paper
• Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery

  2024cited by this paper
• Development of PROTAC Degrader Drugs for Cancer

  2024cited by this paper
• Protective effects of Parkin knockout on asthma-induced changes in juvenile mice: inflammation, airway resistance, and oxidative stress

  2024cited by this paper
• Trim27 aggravates airway inflammation and oxidative stress in asthmatic mice via potentiating the NLRP3 inflammasome.

  2024cited by this paper
• Trim31 deficiency exacerbates airway inflammation in asthma by enhancing the activation of the NLRP3 inflammasome.

  2024cited by this paper
• Oxidative cell death in cancer: mechanisms and therapeutic opportunities

  2024cited by this paper
• TRIM47 promotes HDM‐induced bronchial epithelial pyroptosis by regulating NEMO ubiquitination to activate NF‐κB/NLRP3 signaling

  2024cited by this paper
• Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

  2024cited by this paper
• Deletion of BRCC3 ameliorates airway inflammation in asthma by inhibiting the activation of NLRP3 inflammasome.

  2024cited by this paper
• IL-13 facilitates ferroptotic death in asthmatic epithelial cells via SOCS1-mediated ubiquitinated degradation of SLC7A11

  2024cited by this paper
• MDM2: current research status and prospects of tumor treatment

  2024cited by this paper
• STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases

  2024cited by this paper
• c-CBL/LCK/c-JUN/ETS1/CD28 axis restrains childhood asthma by suppressing Th2 differentiation

  2024cited by this paper
• OTUB1 targets CHK1 for deubiquitinating and stabilizing to facilitate lung cancer progression and radioresistance.

  2024cited by this paper
• USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer

  2024cited by this paper
• MDM2 Is Essential to Maintain the Homeostasis of Epithelial Cells by Targeting p53

  2024cited by this paper
• Cullin5 drives experimental asthma exacerbations by modulating alveolar macrophage antiviral immunity

  2024cited by this paper
• PubChem 2025 update.

  2024cited by this paper
• The application of PROTACs in immune-inflammation diseases.

  2024cited by this paper
• The Effect of a TLR3 Agonist on Airway Allergic Inflammation and Viral Infection in Immunoproteasome-Deficient Mice

  2024cited by this paper
• Chalcone-derivative L6H21 attenuates the OVA-induced asthma by targeting MD2

  2024cited by this paper
• Deubiquitinases in cancer

  2023cited by this paper
• The traditional uses, phytochemistry, pharmacology and toxicology of Bergenia purparescens: A review comments and suggestions

  2023cited by this paper
• Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation

  2023cited by this paper
• Parkin Promotes Airway Inflammatory Response to Interferon Gamma

  2023cited by this paper
• Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019

  2023cited by this paper
• Programmed Cell Death in Asthma: Apoptosis, Autophagy, Pyroptosis, Ferroptosis, and Necroptosis

  2023cited by this paper
• Targeting cullin neddylation for cancer and fibrotic diseases

  2023cited by this paper
• CRL4B complex-mediated H2AK119 monoubiquitination restrains Th1 and Th2 cell differentiation

  2023cited by this paper
• Vialinin A alleviates oxidative stress and neuronal injuries after ischaemic stroke by accelerating Keap1 degradation through inhibiting USP4-mediated deubiquitination.

  2023cited by this paper
• Targeted MDM2 degradation reveals a new vulnerability for p53 inactivated triple negative breast cancer.

  2023cited by this paper
• UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability

  2023cited by this paper
• Hypermethylation of RNF125 promotes autophagy-induced oxidative stress in asthma by increasing HMGB1 stability

  2023cited by this paper
• Protein degraders enter the clinic — a new approach to cancer therapy

  2023cited by this paper
• Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure

  2023cited by this paper
• Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes

  2023cited by this paper
• Current research into A20 mediation of allergic respiratory diseases and its potential usefulness as a therapeutic target

  2023cited by this paper
• Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells

  2023cited by this paper
• The Interaction of OTUB1 and TRAF3 Mediates NLRP3 Inflammasome Activity to Regulate TGF-β1-induced BEAS-2B Cell Injury

  2023cited by this paper
• Immunoproteasome Inhibition Reduces the T Helper 2 Response in Mouse Models of Allergic Airway Inflammation

  2022cited by this paper
• An overview of PROTACs: a promising drug discovery paradigm

  2022cited by this paper
• A Ubiquitination Cascade Regulating the Integrated Stress Response and Survival in Carcinomas

  2022cited by this paper
• Blockade of NLRP3/Caspase-1/IL-1β Regulated Th17/Treg Immune Imbalance and Attenuated the Neutrophilic Airway Inflammation in an Ovalbumin-Induced Murine Model of Asthma

  2022cited by this paper
• Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis.

  2022cited by this paper
• The membrane-associated ubiquitin ligases MARCH2 and MARCH3 target IL-5 receptor alpha to negatively regulate eosinophilic airway inflammation

  2022cited by this paper
• Endothelial Rbpj deletion normalizes Notch4-induced brain arteriovenous malformation in mice

  2022cited by this paper
• Amygdalin alleviated TGF-β-induced epithelial-mesenchymal transition in bronchial epithelial cells.

  2022cited by this paper
• TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2

  2022cited by this paper
• Advances in the Study of the Ubiquitin-Editing Enzyme A20

  2022cited by this paper
• AMFR drives allergic asthma development by promoting alveolar macrophage–derived GM-CSF production

  2022cited by this paper
• Shared Genetic Architecture and Causal Relationship Between Asthma and Cardiovascular Diseases: A Large-Scale Cross-Trait Analysis

  2022cited by this paper
• Altered gene expression levels of IL-17/TRAF6/MAPK/USP25 axis and pro-inflammatory cytokine levels in lung tissue of obese ovalbumin-sensitized rats.

  2022cited by this paper
• Burden of rare coding variants reveals genetic heterogeneity between obese and non-obese asthma patients in the African American population

  2022cited by this paper
• The dichotomous role of immunoproteasome in cancer: Friend or foe?

  2022cited by this paper
• The ubiquitin ligase Cul5 regulates CD4+ T cell fate choice and allergic inflammation

  2022cited by this paper
• A genome-wide association study of serum proteins reveals shared loci with common diseases

  2022cited by this paper
• A20 (Tnfaip3) expressed in CD4+ T cells suppresses Th2 cell-mediated allergic airway inflammation in mice.

  2022cited by this paper
• Sounding the alarmins—The role of alarmin cytokines in asthma

  2022cited by this paper
• Emerging roles of TRIM27 in cancer and other human diseases

  2022cited by this paper
• E3 ubiquitin ligase FBXW7 balances airway cell fates.

  2022cited by this paper
• Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-κB pathway

  2022cited by this paper
• MARCH1 Controls an Exhaustion-like Program of Effector CD4+ T Cells Promoting Allergic Airway Inflammation

  2022cited by this paper
• LncTRPM2-AS inhibits TRIM21-mediated TRPM2 ubiquitination and prevents autophagy-induced apoptosis of macrophages in asthma

  2021cited by this paper
• OTUB1 regulates lung development, adult lung tissue homeostasis, and respiratory control

  2021cited by this paper
• Epithelial Aryl Hydrocarbon Receptor Protects From Mucus Production by Inhibiting ROS-Triggered NLRP3 Inflammasome in Asthma

  2021cited by this paper
• The Role of CD4+ T Cells and Microbiota in the Pathogenesis of Asthma

  2021cited by this paper
• March1-overexpressed dendritic cells downregulate Th1/Th2 ratio in asthma through promoting OX40L.

  2021cited by this paper
• Long non-coding RNA TUG1 promotes proliferation and migration in PDGF-BB-stimulated HASMCs by regulating miR-216a-3p/SMURF2 axis

  2021cited by this paper
• SKP2-Promoted Ubiquitination of FOXO3 Promotes the Development of Asthma

  2021cited by this paper
• Emerging functions of branched ubiquitin chains

  2021cited by this paper
• Bergenin, a PPARγ agonist, inhibits Th17 differentiation and subsequent neutrophilic asthma by preventing GLS1-dependent glutaminolysis

  2021cited by this paper
• USP4 is pathogenic in allergic airway inflammation by inhibiting regulatory T cell response.

  2021cited by this paper
• Mapping the proteo-genomic convergence of human diseases

  2021influential reference
• Proteasome in action: substrate degradation by the 26S proteasome

  2021cited by this paper
• Genetic variations in the PSMA6 and PSMC6 proteasome genes are associated with multiple sclerosis and response to interferon-β therapy in Latvians

  2021influential reference
• Takayasu’s Arteritis Diagnosed in an Adolescent Patient with Crohn’s Disease: Management of Biologicals

  2021cited by this paper
• The ubiquitin proteoform problem.

  2021cited by this paper
• Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma

  2021cited by this paper
• Molecular mechanisms of oxidative stress in asthma.

  2021cited by this paper
• Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response

  2021cited by this paper
• The NLRP3 inflammasome inhibitor, OLT1177®, ameliorates experimental allergic asthma in mice

  2021cited by this paper
• HOXC6-Mediated miR-188-5p Expression Induces Cell Migration through the Inhibition of the Tumor Suppressor FOXN2

  2021cited by this paper
• Single nucleotide polymorphism rs5029937 in TNFAIP3 gene is correlated with risk of rheumatoid arthritis

  2021influential reference
• The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis Development

  2021influential reference
• PARK2 attenuates house dust mite-induced inflammatory reaction, pyroptosis and barrier dysfunction in BEAS-2B cells by ubiquitinating NLRP3.

  2021cited by this paper
• Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study

  2021cited by this paper
• Iguratimod: Novel Molecular Insights and a New csDMARD for Rheumatoid Arthritis, from Japan to the World

  2021cited by this paper
• A genome-wide association study of serum proteins reveals shared loci with common diseases

  2021influential reference

• Molecular Mechanisms of the Ubiquitin-Specific Proteases (USPs) Family in Biliary Tract Cancer and Targeted Intervention Strategies

  2025cites this paper